PPIL2 and myeloproliferative neoplasm: We next collected PBMCs from an independent cohort of JAK2V617F-positive patients with MPN and found the same increase in PPIL2 transcript levels (Figure 3Q) and, more importantly, in its protein levels (Figure 3R).